John M. Evans
CEO · Beam Therapeutics Inc.
- 2024
- Jul 1, 2026
- 6
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies John M. Evans files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- FMR LLC - $10.05M in BEAM purchases and sales in the last 12 months
- Giuseppe Ciaramella - $1.41M in BEAM purchases and sales in the last 12 months
- Christine Bellon - $872K in BEAM purchases and sales in the last 12 months
- Amy Simon - $607K in BEAM purchases and sales in the last 12 months
- Bethany J. Cavanagh - $393K in BEAM purchases and sales in the last 12 months
- Sravan Kumar Emany - $171K in BEAM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is John M. Evans?
John M. Evans is a corporate insider, tracked as CEO of Beam Therapeutics Inc. (BEAM). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did John M. Evans last file a Form 4?
The most recent primary Form 4 on record is dated 1 July 2026, one of 6 filings going back to 2024.
Has John M. Evans been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($7.76M) across all tracked filings.
